Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling.

Uddin MJ, Kim EH, Hannan MA, Ha H

Open source

DOI
10.3390/antiox10020258
Published
2021 Feb 7
Container
Antioxidants (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antiox10020258,
  title = {Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling.},
  author = {Uddin MJ and Kim EH and Hannan MA and Ha H},
  year = {2021},
  journal = {Antioxidants (Basel, Switzerland)},
  doi = {10.3390/antiox10020258},
  url = {https://doi.org/10.3390/antiox10020258}
}

RIS

TY  - JOUR
TI  - Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling.
AU  - Uddin MJ
AU  - Kim EH
AU  - Hannan MA
AU  - Ha H
PY  - 2021
JO  - Antioxidants (Basel, Switzerland)
DO  - 10.3390/antiox10020258
UR  - https://doi.org/10.3390/antiox10020258
ER  - 

APA

MJ, U., EH, K., MA, H., & H, H. (2021). Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling.. Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox10020258

Source records